Change in curve changed the ratio of Cmax [Bioanalytics]

posted by Compliance – India, 2015-03-23 08:39 (4108 d 09:45 ago) – Posting: # 14588
Views: 15,867

Dear All,

I request to share your comment on below issue:

We had run one 4 Way crossover study with 1-800 ng/ml and we get the ratio of Cmax 102%. We have revised the range 0.250- 250 ng/ml. we repeated the same samples which are initially run with 1-800 ng/ml.

After completion of repeat study we got ratio of Cmax 87%.

Now my question is does it impacted due to change in method (i.e. linearity) & processing volume? does the observed change in Cmax ratio is logical and acceptable or any doubt on the method can be raised?

Please note that the difference between the concentration obtain during initial analysis and repeat analysis is around 10-12%.

Please advice and share your thought on this matter.

Regards,

Compliance

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
145 visitors (0 registered, 145 guests [including 26 identified bots]).
Forum time: 19:24 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5